HLA-C and neoplasm: The favorable safety profile and innate tumor-recognition ability of NK cells—attributed to absence of Major Histocompatibility Complex (MHC) molecule expression in NK and short lifespan—may underlie their potential as an alternative to CAR-T approaches [37,39].